Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 85,523,352
  • Shares Outstanding, K 2,027,100
  • Annual Sales, $ 45,006 M
  • Annual Income, $ 8,025 M
  • 60-Month Beta 0.43
  • Price/Sales 1.90
  • Price/Cash Flow 3.36
  • Price/Book 5.14
Trade BMY with:

Options Overview Details

View History
  • Implied Volatility 28.64% ( -0.21%)
  • Historical Volatility 20.66%
  • IV Percentile 92%
  • IV Rank 84.77%
  • IV High 30.66% on 01/29/24
  • IV Low 17.36% on 07/28/23
  • Put/Call Vol Ratio 0.40
  • Today's Volume 23,524
  • Volume Avg (30-Day) 39,209
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 731,928
  • Open Int (30-Day) 774,299

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 1.67
  • Number of Estimates 11
  • High Estimate 1.79
  • Low Estimate 1.55
  • Prior Year 1.75
  • Growth Rate Est. (year over year) -4.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.63 +7.49%
on 06/20/24
43.19 -1.37%
on 06/12/24
+1.36 (+3.30%)
since 05/24/24
3-Month
39.63 +7.49%
on 06/20/24
54.47 -21.80%
on 03/28/24
-9.95 (-18.93%)
since 03/26/24
52-Week
39.63 +7.49%
on 06/20/24
65.38 -34.84%
on 07/24/23
-22.19 (-34.25%)
since 06/26/23

Most Recent Stories

More News
3 No-Brainer Stocks to Buy for Under $100 Right Now

You won't need much money to start investing in these great stocks.

AZN : 79.44 (-0.39%)
BMY : 42.55 (+0.85%)
PFE : 27.33 (-2.36%)
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold

The pharmaceutical industry giants offer reliable profit growth and above-average dividend yields.

KVUE : 18.56 (-0.48%)
PFE : 27.33 (-2.36%)
JNJ : 146.96 (-0.16%)
BMY : 42.55 (+0.85%)
3 Bear Put Spread Trade Ideas For This Thursday

With the market looking a bit extended here, it could be a good idea to add some bearish trades to your options portfolio.

INTC : 30.44 (-0.98%)
CLF : 14.81 (+2.49%)
BMY : 42.55 (+0.85%)
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data

/CNW/ -- USA News Group – This year's 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not without increasing...

ONCY : 1.0400 (+2.97%)
ABBV : 171.74 (+0.58%)
AZN : 79.44 (-0.39%)
PFE : 27.33 (-2.36%)
BMY : 42.55 (+0.85%)
ONC.TO : 1.41 (+2.92%)
Key Takeaways from the 2024 ASCO Annual Meeting: Promising Developments in Cancer Care

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – This year’s 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not...

ONCY : 1.0400 (+2.97%)
ONC.TO : 1.41 (+2.92%)
ABBV : 171.74 (+0.58%)
AZN : 79.44 (-0.39%)
PFE : 27.33 (-2.36%)
BMY : 42.55 (+0.85%)
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb

These two pharma stocks are beloved by income investors.

PFE : 27.33 (-2.36%)
BMY : 42.55 (+0.85%)
How Is Bristol-Myers Squibb's Stock Performance Compared to Other General Drug Manufacturers?

Bristol-Myers Squibb has been lagging behind other drug manufacturers over the past three months, and analysts remain cautious about the stock's prospects.

BMY : 42.55 (+0.85%)
XPH : 39.90 (-0.32%)
AZN : 79.44 (-0.39%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:BPTH),(NASDAQ:LGVN),(NASDAQ:SLS),(NYSE:BMY) EQNX::TICKER_END

ATNM : 7.39 (+3.21%)
BPTH : 2.10 (unch)
LGVN : 1.7300 (-7.98%)
SLS : 1.1250 (-3.85%)
BMY : 42.55 (+0.85%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase

ATNM : 7.39 (+3.21%)
BPTH : 2.10 (unch)
LGVN : 1.7300 (-7.98%)
SLS : 1.1250 (-3.85%)
BMY : 42.55 (+0.85%)
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade

Their prices might not be done falling, but you can count on the dividends they distribute to continue rising steadily.

PFE : 27.33 (-2.36%)
BMY : 42.55 (+0.85%)
CVS : 60.76 (+0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 43.30
2nd Resistance Point 42.84
1st Resistance Point 42.51
Last Price 42.57
1st Support Level 41.72
2nd Support Level 41.26
3rd Support Level 40.93

See More

52-Week High 65.38
Fibonacci 61.8% 55.54
Fibonacci 50% 52.50
Fibonacci 38.2% 49.46
Last Price 42.57
52-Week Low 39.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar